首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1410058

2023年至2028年早產及胎膜早破檢驗市場預測

Preterm Birth and Prom Testing Market - Forecasts from 2023 to 2028

出版日期: 2023年12月11日 | 出版商:

Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

早產和胎膜早破檢測市場預計將從 2021 年的 15.1 億美元成長到 2028 年的 21.29 億美元，複合年成長率為 5.03%。

早產和胎膜早破測試可以幫助辨識孕婦的胎膜破裂情況。識別破裂的胎膜使我們能夠治療患者並避免早產。由於生活方式障礙和壓力等多種因素導致的早產和胎膜早破病例不斷增加，是早產和胎膜早破檢測市場的主要成長要素。此外，孕婦青少年懷孕和妊娠毒血症病例的增加也預計將對早產和胎膜早破檢測市場產生正面影響。此外，政府舉措以及市場參與企業的產品發布和研究計劃預計也將推動早產和胎膜早破測試市場的發展。

早產增加

由於不良生活習慣等多種因素導致的早產增加表明早產和胎膜早破檢測市場的擴大。根據世界衛生組織統計，2020年報告了1,340萬例早產（妊娠37週前出生），各國早產率介於4%至16%之間。此外，南亞和撒哈拉以南非洲地區的早產率最高，這些地區的早產兒死亡率也最高。全球65%以上的早產兒集中在這兩個地區。

早產的負面影響

與早產和胎膜早破相關的眾多併發症表明需要早期發現和預防早產，從而推動早產和胎膜早破檢測市場的發展。例如，五歲以下兒童的主要死因是早產，2019年約有90萬人死於早產。這可能是由呼吸系統不發達引起的呼吸問題、開放性動脈導管和低血壓等心臟問題引起的。慢性健康問題，如壞死性小腸結腸炎、貧血、新生兒黃疸、低血糖、腦性麻痹、牙齒問題、感染疾病、氣喘和飲食障礙，都是早產兒可能發生的長期併發症。這是一個例子影響。

青少年懷孕和妊娠毒血症呈上升趨勢

早產與青春期妊娠、妊娠毒血症孕產婦健康問題密切相關。因此，青少年懷孕的增加和妊娠毒血症病例的增加預計將擴大早產和胎膜早破檢測市場。據 NCBI 稱，妊娠毒血症併發症每年導致 50,000 名孕產婦死亡和 50 萬名胎兒死亡。青春期母親（10至19歲）比女性（20至24歲）更容易患子癇、產後子宮內膜炎和全身性行為感染，並且更容易出現低出生體重、早產和嚴重疾病。其後代的新生兒疾病發病率更高。根據世界衛生組織預測，到2022年，全球10至14歲女性的青少年生育率為每1,000名女性生育1.5個孩子。

政府措施和研究計劃

政府措施和研究計劃正在推動胎膜早破測試的進步和採用，從而推動早產和胎膜早破測試市場的發展。例如，在低收入和中等收入國家，世衛組織進行研究以改善對孕婦和早產兒的照護。這些研究包括世衛組織行動試驗（使用產前皮質類固醇改善早產兒結局）、嬰兒早期生長擺動的營養管理試驗以及擴大袋鼠母親即時護理（KMC）規模的實施研究試驗。此外，國際婦產科日誌(FIGO) 在 2021 年 10 月號的《國際婦產科雜誌》中推出了一個特別版塊。本期特刊包括FIGO 關於有效管理和監測早產的九項良好實務建議。

北美地區預計將大幅成長

在預測期內，北美地區預計將佔據早產和胎膜早破測試市場的主要佔有率。造成這一比例的因素包括早產率上升、技術進步以及意識的提高。例如，根據CDC資料，2021年的早產率比2020年增加了4%，為2007年以來最高，2021年美國出生的嬰兒中大約有十分之一會遭受早產。。

主要市場公司

Hologic Inc. 是一家總部位於美國的跨國公司，專注於女性健康領域。一種稱為快速 fFN(R) 的周產期測試可評估孕婦早產的風險。該公司提供的其他早產和胎膜早破檢測套組包括 QuikCheck fFN(R) 測試套件和 Rapid fFN(R) 10Q 盒式套件。 Sera Prognotics Inc. 是領先的女性健康公司之一，總部位於美國。 2023 年 2 月，該公司宣布了 Avert 早產試驗關於降低新生兒發病率或死亡的積極頂線資料。這項研究是在威爾明頓的克里斯蒂娜護理中心進行的。

Preterm birth and PROM testing aid in identifying fetal membrane rapture in pregnant women. The patient can be treated and a preterm birth can be avoided by identifying the ruptured fetal membrane. The rising cases of preterm birth and PROM due to several factors such as bad lifestyle, and stress are a major growth driver in the preterm birth and PROM testing market. Moreover, the increasing adolescent pregnancies and preeclampsia cases among pregnant women are further expected to positively impact the preterm birth and PROM testing market. Additionally, government efforts coupled with product launches and research projects by the market players are also contemplated to boost the preterm birth and PROM testing market.

Rising Cases of Preterm Birth

The increasing number of preterm births due to several factors such as bad lifestyle indicates the widening of the preterm birth and PROM testing market. In 2020, there were reportedly 13.4 million preterm births (births that occurred before 37 full weeks of pregnancy) according to the WHO, and Preterm birth rates in 2020 ranged from 4 to 16% across all nations. Moreover, preterm birth rates are highest in southern Asia and sub-Saharan Africa, and preterm infants in these areas have the highest mortality rates. More than 65% of preterm births worldwide are concentrated in these two areas. The study conducted by the Department of Obstetrics and Gynecology (University of Addis Ababa) in December 2022 revealed that the preterm PROM rate was 2.2% with a perinatal mortality rate of 206/1000.

Adverse Effects of Preterm Birth

There are numerous complications associated with preterm births and PROM which indicates the requirement of early detection and prevention of preterm births thereby propelling the preterm birth and PROM testing market. For instance, the primary factor in the death of children under the age of five is preterm birth problems, which accounted for almost 900,000 deaths in 2019. Breathing issues brought on by an underdeveloped respiratory system, heart issues including patent ductus arteriosus and low blood pressure, and other brief consequences are possible in people born preterm. Bleeding inside the head complications with the digestive system that can lead to necrotizing enterocolitis, anemia, and neonatal jaundice, hypoglycemia, cerebral palsy, learning disabilities, dental troubles, and chronic health conditions like infections, asthma, and feeding difficulties are examples of long-term repercussions that can affect the people born preterm.

Increasing Adolescent Pregnancy and Preeclampsia Cases

Preterm deliveries are closely associated with maternal health hazards, such as adolescent pregnancy and pre-eclampsia. The rising number of adolescent pregnancies and increasing preeclampsia cases are therefore contemplated to augment the preterm birth and PROM testing market. Preeclampsia complications cause 50,000 maternal deaths and 500,000 fetal deaths annually, according to NCBI. The chances of eclampsia, puerperal endometritis, and systemic infections are higher for adolescent mothers (10-19 years old) than for women (20-24 years old), and the risks of low birth weight, preterm birth, and severe neonatal conditions are higher for their offspring. According to the WHO, the anticipated global adolescent birth rate for females aged 10 to 14 in 2022 was 1.5 per 1000 women.

Government Efforts and Research Projects

The government efforts and research projects are encouraging the advancement and adoption of PROM testing thereby propelling the preterm birth and PROM testing market. For instance, in low- and middle-income nations, the WHO conducts research to improve care for pregnant women and preterm infants. These studies include the WHO ACTION Trials (Antenatal Corticosteroids for Improving Outcomes in Preterm Newborns), the Nutritional Management of Growth Flapping in Early Infancy Trial, and an implementation research trial to scale-up immediate kangaroo mother care (KMC). Moreover, the International Federation of Gynecology and Obstetrics (FIGO) launched a special section in the October 2021 issue of the International Journal of Gynecology and Obstetrics. This special section contains nine FIGO good practice recommendations for the effective management and monitoring of preterm birth.

North America is expected to grow Significantly

The North American region is expected to hold a significant share of the preterm birth and PROM testing market during the forecast period. Various factors attributed to such a share are the rising rate of preterm births, and technological advancements coupled with increased awareness. For instance, the preterm birth rate increased by 4% in 2021 as compared to 2020 which is the highest since 2007 as per the CDC data, and around one in 10 babies born in the US in 2021 suffered from preterm birth. Moreover, the presence of major market players such as Hologic, Abbott Laboratories, and Sera Prognostics Inc. is further expected to boost the preterm birth and PROM testing market in the region through enhanced accessibility.

Major Market Players

Hologic Inc. is a US-based multinational company focused on women's health. Perinatal testing called Rapid fFN® assesses a pregnant woman's risk of having a preterm birth. Other preterm and PROM kits offered by the company are the QuikCheck fFN® Test kit, Rapid fFN® 10Q Cassette Kit.
Sera Prognotics Inc. is one of the leading women's health companies headquartered in the US. In February 2023, the company announced the positive top-line data from Avert Preterm Trial in the reduction of neonatal morbidity or neonatal death. It was conducted at ChristianaCare in Wilmington.

Key Market Developments

In January 2023, to advance maternal health equity, the March of Dimes established a new preterm research centre at the University of Pennsylvania. It focuses on resolving the persistent racial inequities and poor health outcomes that make the United States the riskiest developed country for giving birth.
In August 2022, March of Dimes launched a new prematurity research hum at the University of California which focuses on using big data to gain insights into diagnostic and therapeutic tools to combat prematurity.

Segmentation:

By Preterm Birth Tests

Pelvic exam
Ultrasound
Others

By PROM Tests

Nitrazine Test
Ferning Test
Others

By End-User

Diagnostic Laboratories
Hospitals
Others

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Thailand
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Force Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. PRETERM BIRTH AND PROM TESTING MARKET, BY PRETERM BIRTH TESTS

5.1. Introduction
5.2. Pelvic exam
5.3. Ultrasound
5.4. Others

6. PRETERM BIRTH AND PROM TESTING MARKET, BY PROM TESTS

6.1. Introduction
6.2. Nitrazine Test
6.3. Ferning Test
6.4. Others

7. PRETERM BIRTH AND PROM TESTING MARKET, BY END-USER

7.1. Introduction
7.2. Diagnostic Laboratories
7.3. Hospitals
7.4. Others

8. PRETERM BIRTH AND PROM TESTING MARKET, BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. United States
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. United Kingdom
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Spain
- 8.4.5. Others
8.5. The Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Israel
- 8.5.4. Others
8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others